CIK 0001668243 · Non-accelerated filer<br>Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 9 770 7601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- 8-K Event Regulation FD disclosure
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- SC 13G Stake Amended Statement of Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Material agreement · Other events
- 8-K Event Material agreement
- SC 13G Stake Amended Statement of Ownership
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- EFFECT Other Notice of Effectiveness
Page 10 of 30 · 583 filings